Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Zirlik

Showing results (1-10 of 201) with videos related to

Pageof 21
Sort By:
Thrombosis and Haemostasis|March 18, 2004
TAFI: a promising drug target?Andreas Zirlik
Journal of Thrombosis and Thrombolysis|November 30, 2016
Vitamin K antagonists: relative strengths and weaknesses vs. direct oral anticoagulants for stroke prevention in patients with atrial fibrillationAndreas Zirlik, Christoph Bode
Cardiovascular Research|March 29, 2020
Immunometabolism: a key target to improve microcirculation in ageingMahmoud Abdellatif, Andreas Zirlik
European Heart Journal|May 29, 2007
STEMI and NSTEMI: the dangerous brothersChristoph Bode, Andreas Zirlik
Nature Reviews. Cardiology|May 22, 2023
Identifying leukocyte phenotypes by scRNA-seq to predict cardiovascular riskJohannes Gollmer, Andreas Zirlik
Hamostaseologie|December 23, 2021
Anti-inflammatory Strategies in AtherosclerosisHeiko Bugger, Andreas Zirlik
Antioxidants & Redox Signaling|May 15, 2020
Pathogenic Role of Air Pollution Particulate Matter in Cardiometabolic Disease: Evidence from Mice and HumansTimoteo Marchini, Andreas Zirlik, Dennis Wolf
Case Reports in Vascular Medicine|August 13, 2013
Successful therapy of ventricular rupture by percutaneous intrapericardial instillation of fibrin glue: a case reportFlorian Willecke, Christoph Bode, Andreas Zirlik
Diabetes & Metabolism Journal|February 26, 2020
Mitochondrial Mechanisms in Diabetic CardiomyopathyJohannes Gollmer, Andreas Zirlik, Heiko Bugger
International Journal of Cardiology|July 27, 2007
Anaphylactic shock-associated cardiomyopathyMaximilian Hartmann, Christoph Bode, Andreas Zirlik
Pageof 21

Showing results (1-10 of 201) with videos related to

Sort By:
Pageof 21
Thrombosis and Haemostasis|March 18, 2004
TAFI: a promising drug target?Andreas Zirlik
Journal of Thrombosis and Thrombolysis|November 30, 2016
Vitamin K antagonists: relative strengths and weaknesses vs. direct oral anticoagulants for stroke prevention in patients with atrial fibrillationAndreas Zirlik, Christoph Bode
Cardiovascular Research|March 29, 2020
Immunometabolism: a key target to improve microcirculation in ageingMahmoud Abdellatif, Andreas Zirlik
European Heart Journal|May 29, 2007
STEMI and NSTEMI: the dangerous brothersChristoph Bode, Andreas Zirlik
Nature Reviews. Cardiology|May 22, 2023
Identifying leukocyte phenotypes by scRNA-seq to predict cardiovascular riskJohannes Gollmer, Andreas Zirlik
Hamostaseologie|December 23, 2021
Anti-inflammatory Strategies in AtherosclerosisHeiko Bugger, Andreas Zirlik
Antioxidants & Redox Signaling|May 15, 2020
Pathogenic Role of Air Pollution Particulate Matter in Cardiometabolic Disease: Evidence from Mice and HumansTimoteo Marchini, Andreas Zirlik, Dennis Wolf
Case Reports in Vascular Medicine|August 13, 2013
Successful therapy of ventricular rupture by percutaneous intrapericardial instillation of fibrin glue: a case reportFlorian Willecke, Christoph Bode, Andreas Zirlik
Diabetes & Metabolism Journal|February 26, 2020
Mitochondrial Mechanisms in Diabetic CardiomyopathyJohannes Gollmer, Andreas Zirlik, Heiko Bugger
International Journal of Cardiology|July 27, 2007
Anaphylactic shock-associated cardiomyopathyMaximilian Hartmann, Christoph Bode, Andreas Zirlik
Pageof 21